Sandra Iden

Sandra Iden

Auto-generated profile, based on publicly available information

Sandra Iden

Saarland University

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2008 in Nature Reviews Molecular Cell Biology
Verified
Journal Article
Closed access
PDF file
SISandra Iden
Sandra Iden
JCJohn G. Collard
John G. Collard

1 April 2005 in Endocrinology
Verified
Journal Article
Closed access
HHHeike Heuer
Heike Heuer
MMMichael K. Maier
Michael K. Maier
SISandra Iden
Sandra Iden
JMJens Mittag
Jens Mittag
EFEdith C. H. Friesema
Edith C. H. Friesema
KBKarl Bauer
Karl Bauer
Recent genetic analysis in several patients presenting a severe form of X-linked psychomotor retardation combined with abnormal thyroid hormone (TH) levels have revealed mutations or deletions in the gene of the monocarboxylate transporter 8 (MCT8). Because in vitro MCT8 functions as a TH transporter, the complex clinical picture of these patients indicated an important role for MCT8 in TH-dependent processes of brain development. To provide a clue to the cellular function of MCT8 in brain, we studied the expression of MCT8 mRNA in the murine central nervous system by in situ hybridization histochemistry. In addition to the choroid plexus structures, the highest transcript levels were found in neo- and allocortical regions (e.g. olfactory bulb, cerebral cortex, hippocampus, and amygdala), moderate signal intensities in striatum and cerebellum, and low levels in a few neuroendocrine nuclei. Colocalization studies revealed that MCT8 is predominantly expressed in neurons. Together with the spatiotemporal expression pattern of MCT8 during the perinatal period, these results strongly indicate that MCT8 plays an important role for proper central nervous system development by transporting TH into neurons as its main target cells.

1 August 2012 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
OSOliver Semler
Oliver Semler
LGLutz Garbes
Lutz Garbes
KKKatharina Keupp
Katharina Keupp
DSDaniel Swan
Daniel Swan
KZKatharina Zimmermann
Katharina Zimmermann
CNChristian Netzer
Christian Netzer

29 June 2007 in Cell Death & Differentiation
Verified
Journal Article
Closed access
JPJulian Pardo
Julian Pardo
RWR Wallich
R Wallich
KEKlaus Ebnet
Klaus Ebnet
SIS Iden
S Iden
HZH Zentgraf
H Zentgraf
MSM M Simon
M M Simon

1 June 2012 in Seminars in Cancer Biology
Verified
Journal Article
Closed access
SESaskia I.J. Ellenbroek
Saskia I.J. Ellenbroek
SISandra Iden
Sandra Iden
JCJohn G. Collard
John G. Collard

27 October 2016 in Nature Communications
Verified
Journal Article
Open access
PDF file
XDXiaolei Ding
Xiaolei Ding
WBWilhelm Bloch
Wilhelm Bloch
SISandra Iden
Sandra Iden
MRMarkus A. Rüegg
Markus A. Rüegg
MHMichael N. Hall
Michael N. Hall
SESabine A. Eming
Sabine A. Eming
Mammalian target of rapamycin (mTOR), a regulator of growth in many tissues, mediates its activity through two multiprotein complexes, mTORC1 or mTORC2. The role of mTOR signalling in skin morphogenesis and epidermal development is unknown. Here we identify mTOR as an essential regulator in skin morphogenesis by epidermis-specific deletion of Mtor in mice (mTOREKO). mTOREKO mutants are viable, but die shortly after birth due to deficits primarily during the early epidermal differentiation programme and lack of a protective barrier development. Epidermis-specific loss of Raptor, which encodes an essential component of mTORC1, confers the same skin phenotype as seen in mTOREKO mutants. In contrast, newborns with an epidermal deficiency of Rictor, an essential component of mTORC2, survive despite a hypoplastic epidermis and disruption in late stage terminal differentiation. These findings highlight a fundamental role for mTOR in epidermal morphogenesis that is regulated by distinct functions for mTORC1 and mTORC2.